Literature DB >> 19704418

Signalling crosstalk in B cells: managing worth and need.

Michael P Cancro1.   

Abstract

The B cell receptor (BCR) and the receptor for B cell-activating factor (BAFFR) have complementary roles in B cells: BCR signals provide a cell-intrinsic measure of suitability for negative or positive selection, whereas BAFFR responds to homeostatic demands based on a cell-extrinsic measure of the size of the mature B cell pool. Because continuous signals from both receptors are required for B cell survival, it is probable that there are mechanisms to integrate the selective and homeostatic signals from these receptors. In this Opinion article, I describe recent evidence to indicate that crosstalk between the downstream biochemical pathways of these receptors mediates this interdependence, such that BCR signals generate a limiting substrate for BAFFR signal propagation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19704418      PMCID: PMC2766863          DOI: 10.1038/nri2621

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  62 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

4.  Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase.

Authors:  T Yamada; T Mitani; K Yorita; D Uchida; A Matsushima; K Iwamasa; S Fujita; M Matsumoto
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

5.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

6.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.

Authors:  Brian D Hondowicz; Shawn T Alexander; William J Quinn; Antonio J Pagán; Michele H Metzgar; Michael P Cancro; Jan Erikson
Journal:  Int Immunol       Date:  2007-03-15       Impact factor: 4.823

8.  Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

Authors:  Jason E Stadanlick; Mary Kaileh; Fredrick G Karnell; Jean L Scholz; Juli P Miller; William J Quinn; Randall J Brezski; Laura S Treml; Kimberly A Jordan; John G Monroe; Ranjan Sen; Michael P Cancro
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

9.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  BAFF mediates survival of peripheral immature B lymphocytes.

Authors:  M Batten; J Groom; T G Cachero; F Qian; P Schneider; J Tschopp; J L Browning; F Mackay
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  55 in total

1.  TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.

Authors:  Zhangguo Chen; Alexandra Krinsky; Rachel A Woolaver; Xiaoguang Wang; Samantha M Y Chen; Vince Popolizio; Ping Xie; Jing H Wang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Recruitment of a distinct but related set of VH sequences into the murine CD21hi/CD23- marginal zone B cell repertoire to that seen in the class-switched antibody response.

Authors:  Henry N White; Qing-Hai Meng
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

Review 3.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

4.  Tweaking the B lymphocyte compartment in autoimmune diseases.

Authors:  Moncef Zouali
Journal:  Nat Immunol       Date:  2014-03       Impact factor: 25.606

5.  Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.

Authors:  Sarah E M Herman; Rashida Z Mustafa; Jennifer A Gyamfi; Stefania Pittaluga; Stella Chang; Betty Chang; Mohammed Farooqui; Adrian Wiestner
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

Review 6.  Aberrant B-cell homeostasis in chronic GVHD.

Authors:  Stefanie Sarantopoulos; Jerome Ritz
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

Review 7.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 8.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

9.  The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis.

Authors:  Toshiharu Abe; Mohammed AlSarhan; Manjunatha R Benakanakere; Tomoki Maekawa; Denis F Kinane; Michael P Cancro; Jonathan M Korostoff; George Hajishengallis
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

10.  G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity.

Authors:  Ravi S Misra; Guixiu Shi; Miguel E Moreno-Garcia; Anil Thankappan; Michael Tighe; Betty Mousseau; Kim Kusser; Shirly Becker-Herman; Kelly L Hudkins; Robert Dunn; Marilyn R Kehry; Thi-Sau Migone; Ann Marshak-Rothstein; Melvin Simon; Troy D Randall; Charles E Alpers; Denny Liggitt; David J Rawlings; Frances E Lund
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.